| Primary |
| Colon Cancer |
20.2% |
| Rectal Cancer |
12.2% |
| Colorectal Cancer |
11.8% |
| Colorectal Cancer Metastatic |
9.7% |
| Drug Use For Unknown Indication |
6.6% |
| Gastric Cancer |
4.8% |
| Colon Cancer Metastatic |
4.6% |
| Premedication |
4.5% |
| Hypertension |
3.5% |
| Large Intestine Carcinoma |
2.9% |
| Prophylaxis |
2.6% |
| Product Used For Unknown Indication |
2.4% |
| Oesophageal Carcinoma |
2.3% |
| Pancreatic Carcinoma |
2.3% |
| Rectal Cancer Metastatic |
2.2% |
| Chemotherapy |
2.1% |
| Nausea |
2.0% |
| Pain |
1.4% |
| Neoplasm Malignant |
1.0% |
| Metastases To Liver |
0.9% |
|
| Vomiting |
19.8% |
| Thrombocytopenia |
10.2% |
| Death |
8.4% |
| Sepsis |
5.4% |
| Myocardial Infarction |
5.4% |
| Diarrhoea |
5.1% |
| Pyrexia |
4.6% |
| Respiratory Failure |
4.3% |
| Renal Failure Acute |
3.5% |
| Gastrointestinal Perforation |
3.3% |
| White Blood Cell Count Decreased |
3.3% |
| Nausea |
3.3% |
| Stomatitis |
3.1% |
| Transient Ischaemic Attack |
3.1% |
| Neutropenia |
3.0% |
| Septic Shock |
3.0% |
| Syncope |
2.9% |
| Dyspnoea |
2.8% |
| Pneumonia |
2.8% |
| Cardiac Arrest |
2.7% |
|
| Secondary |
| Colon Cancer |
18.0% |
| Colorectal Cancer |
14.8% |
| Colorectal Cancer Metastatic |
14.2% |
| Drug Use For Unknown Indication |
12.3% |
| Rectal Cancer |
9.3% |
| Colon Cancer Metastatic |
5.3% |
| Gastric Cancer |
4.1% |
| Hypertension |
3.2% |
| Prophylaxis |
2.6% |
| Premedication |
2.4% |
| Product Used For Unknown Indication |
2.2% |
| Pancreatic Carcinoma |
2.1% |
| Rectal Cancer Metastatic |
1.8% |
| Pain |
1.4% |
| Nausea |
1.4% |
| Large Intestine Carcinoma |
1.2% |
| Metastases To Liver |
1.1% |
| Non-hodgkin's Lymphoma |
0.9% |
| Breast Cancer |
0.9% |
| Prophylaxis Of Nausea And Vomiting |
0.9% |
|
| Vomiting |
19.0% |
| Pyrexia |
8.9% |
| Thrombocytopenia |
6.9% |
| Diarrhoea |
6.3% |
| Death |
5.4% |
| Sepsis |
5.1% |
| Interstitial Lung Disease |
4.2% |
| White Blood Cell Count Decreased |
4.2% |
| Neutropenia |
4.1% |
| Disease Progression |
4.0% |
| Renal Failure Acute |
3.5% |
| Neuropathy Peripheral |
3.4% |
| Pulmonary Embolism |
3.4% |
| Stomatitis |
3.3% |
| Pneumonia |
3.2% |
| Respiratory Failure |
3.2% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
3.1% |
| Renal Failure |
3.0% |
| Nausea |
3.0% |
| Febrile Neutropenia |
2.9% |
|
| Concomitant |
| Colorectal Cancer |
19.2% |
| Drug Use For Unknown Indication |
15.5% |
| Colorectal Cancer Metastatic |
12.2% |
| Colon Cancer |
12.1% |
| Colon Cancer Metastatic |
9.1% |
| Rectal Cancer |
4.3% |
| Rectal Cancer Metastatic |
3.6% |
| Prophylaxis |
2.8% |
| Product Used For Unknown Indication |
2.5% |
| Gastrooesophageal Cancer |
2.1% |
| Large Intestine Carcinoma |
2.1% |
| Chemotherapy |
2.0% |
| Premedication |
1.9% |
| Nausea |
1.7% |
| Gastric Cancer |
1.6% |
| Hypertension |
1.6% |
| Colon Cancer Recurrent |
1.6% |
| Rectal Cancer Recurrent |
1.5% |
| Pain |
1.3% |
| Pancreatic Carcinoma |
1.3% |
|
| Death |
11.3% |
| Disease Progression |
11.1% |
| Vomiting |
10.9% |
| Interstitial Lung Disease |
8.0% |
| Diarrhoea |
5.8% |
| Pyrexia |
5.7% |
| Sepsis |
4.2% |
| Rash |
4.1% |
| Thrombocytopenia |
4.1% |
| Pulmonary Embolism |
3.9% |
| Neutropenia |
3.7% |
| Stomatitis |
3.7% |
| Weight Decreased |
3.6% |
| White Blood Cell Count Decreased |
3.5% |
| Nausea |
3.4% |
| Neuropathy Peripheral |
2.9% |
| Dermatitis Acneiform |
2.7% |
| Intestinal Obstruction |
2.7% |
| Dyspnoea |
2.5% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
2.4% |
|
| Interacting |
| Colorectal Cancer Metastatic |
15.4% |
| Drug Use For Unknown Indication |
11.5% |
| Rectal Cancer |
11.5% |
| Hiv Infection |
7.7% |
| Colon Cancer |
6.4% |
| Colon Cancer Stage Iv |
5.1% |
| Epilepsy |
5.1% |
| Product Used For Unknown Indication |
5.1% |
| Adenocarcinoma Gastric |
3.8% |
| Bone Lesion |
3.8% |
| Colon Cancer Metastatic |
3.8% |
| Rectal Cancer Metastatic |
3.8% |
| Ascites |
2.6% |
| Colon Neoplasm |
2.6% |
| Colorectal Cancer |
2.6% |
| Metastases To Bone |
2.6% |
| Premedication |
2.6% |
| Atrial Fibrillation |
1.3% |
| Crohn's Disease |
1.3% |
| Depression |
1.3% |
|
| Epilepsy |
15.4% |
| Thrombocytopenia |
15.4% |
| Drug Interaction |
11.5% |
| Gastrointestinal Carcinoma |
7.7% |
| Renal Failure Acute |
7.7% |
| Vomiting |
7.7% |
| Blood Bilirubin Increased |
3.8% |
| Haematuria |
3.8% |
| Interstitial Lung Disease |
3.8% |
| Lethargy |
3.8% |
| Mononeuropathy Multiplex |
3.8% |
| Polyneuropathy |
3.8% |
| Pulmonary Granuloma |
3.8% |
| Septic Shock |
3.8% |
| Transaminases Increased |
3.8% |
|
